文献速递慢性静脉疾病静脉血栓栓塞

孤立性大隐静脉血栓并发症率高且与治疗方式无关

Isolated Great Saphenous Vein Thrombus Is Associated with High Rates of Complications regardless of Management.
PubMed 文献 · Ann Vasc Surg · 2017-06-06

本研究回顾性分析61例孤立性大隐静脉血栓(GSVT)患者,发现38.8%的患者在平均随访761天后仍有症状,7例发生肺栓塞(PE),且PE均见于血栓距隐股交界(SFJ)<5cm者。治疗方式异质性大,但治疗类型似乎不影响结局。

要点

  • 孤立性GSVT患者并发症风险高,包括症状持续、复发、深静脉血栓和肺栓塞。
  • GSVT距SFJ<5cm与肺栓塞风险增加相关(P=0.02)。
  • GSVT距SFJ>5cm与血栓进展/新发浅静脉血栓相关(P=0.048)。

核心结论

  • 孤立性GSVT患者有显著的持续症状、复发、深静脉血栓和肺栓塞风险。
  • 治疗方式异质性大,但治疗类型似乎不影响结局。
  • GSVT距SFJ<5cm似乎与肺栓塞风险增加相关。
  • GSVT距SFJ>5cm似乎与血栓进展/新发浅静脉血栓相关。

研究设计与样本

  • 回顾性队列研究,纳入2008年7月至2014年6月间经下肢静脉双功超声诊断为孤立性GSVT(不伴深静脉血栓)的患者。
  • 共61例患者67条肢体纳入研究组,来自605例急性GSVT患者。

主要发现

  • 14.8%的患者存在高凝状态,31.1%有GSVT或深静脉血栓史,23.0%有恶性肿瘤。
  • 28.4%的GSVT仅观察,13.4%使用阿司匹林/非甾体抗炎药,58.2%接受抗凝治疗。
  • 平均随访761天时,38.8%的肢体在治疗后仍有症状。
  • 7例患者发生肺栓塞,全部位于GSVT距SFJ<5cm组(P=0.02)。

关键数值与推荐

  • GSVT距SFJ<5cm定义为组1(37条肢体),>5cm定义为组2(30条肢体)。
  • 随访超声亚组中,组1有13例(44.8%),组2有16例(55.2%)。
  • 深静脉血栓发生率组1为15.3%(2条肢体),组2为25%(4条肢体)。

临床怎么用

  • 对孤立性GSVT应警惕肺栓塞风险,尤其当血栓距SFJ<5cm时。
  • 距SFJ>5cm的GSVT需关注血栓进展和新发浅静脉血栓。
  • 治疗方式选择不影响结局,但需个体化评估高凝状态、静脉血栓栓塞史、恶性肿瘤等危险因素。

局限性

  • 回顾性研究设计。
  • 随访超声仅覆盖43.3%的肢体,平均随访时间23天。
  • 样本量较小(61例患者)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Isolated great saphenous vein thrombus (GSVT) is generally regarded as benign, and treatment is heterogeneous. Complications include thrombus propagation, new saphenous vein thrombosis, deep vein thrombosis (DVT), pulmonary embolism (PE), and symptom persistence. Our objective was to review our institution's experience with isolated GSVT to understand its natural history, the frequency of complications, real-world treatment, and the impact of proximity to the saphenofemoral junction (SFJ), on the rate of complications. METHODS: Records of patients who had lower extremity venous duplex (LEVD) demonstrating GSVT without concomitant DVT between July 2008 and June 2014 were reviewed. Demographic, medical, management, outcomes, and follow-up LEVD data were collected. RESULTS: Of 605 patients with acute GSVT, 67 limbs in 61 patients with isolated GSVT were the study group; 14.8% of patients had a hypercoagulable state, 31.1% had prior GSVT or DVT, and 23.0% of patients had malignancy; 28.4% of GSVT were observed, 13.4% were treated with aspirin/NSAIDs, and 58.2% were anticoagulated; 38.8% of limbs remained symptomatic following treatment at a mean follow-up period of 761 days; 37 limbs had GSVT <5 cm of the SFJ (group 1), and 30 had GSVT >5 cm from the SFJ (group 2). Seven patients developed PE, all in group 1 (P = 0.02). Twenty-nine limbs (43.3%) had follow-up LEVD at a mean of 23 days. In this subset, 13 patients at the initial scan (44.8%) had thrombus <5 cm of the SFJ (group 1) and 16 (55.2%) had thrombus >5 cm from the SFJ (group 2). Five limbs (17.2%) had GSVT propagation/new superficial vein thrombosis (SVT), and 6 (20.7%) developed new DVT. There was no GSVT propagation/new SVT in group 1, whereas 5 limbs (31.2%) had GSVT propagation/new SVT in group 2 (P = 0.048). DVT occurred in 2 limbs (15.3%) in group 1 and 4 limbs (25%) in group 2. CONCLUSIONS: Isolated GSVT tends to affect patients with hypercoagulable states, prior venous thromboembolism, malignancy, or recent surgery. Management is heterogeneous, and type of treatment does not seem to affect outcomes. Patients with GSVT have significant risk of persistent symptoms, recurrence, DVT, and PE. GSVT within 5 cm of the SFJ seemed to be associated with an increased rate of PE. GSVT more than 5 cm from the SFJ seemed to be associated with propagation/new SVT. Proximity to the SFJ did not impact occurrence of DVT.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Kudlaty E, Oriowo B, Yang MJ, et al. Isolated Great Saphenous Vein Thrombus Is Associated with High Rates of Complications regardless of Management. Ann Vasc Surg. 2017. PMID: 28600022. doi:10.1016/j.avsg.2017.05.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。